Cancer

Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types

UTSW researchers who developed a nanoparticle vaccine for cancer immunotherapy include (l-r) Drs. Min Luo, Jinming Gao, Zhijian “James” Chen, Zhaohui Wang, and Hua Wang. DALLAS – April 24, 2017 – Researchers from UT Southwestern Medical Center have developed a first-of-its-kind nanoparticle vaccine immunotherapy that targets several different cancer types. The nanovaccine consists of tumor antigens

New Bone-In Technique Tests Therapies for Breast Cancer Metastasis

Fri, 04/21/2017 - 10:14am by Baylor College of Medicine Dr. Xiang Zhang, associate professor of molecular and cellular biology and the Lester and Sue Smith Breast Center, and McNair Scholar at Baylor College of Medicine. Credit: Baylor College of Medicine A new laboratory technique developed by researchers at Baylor College of Medicine and other institutions can

Could a Dog Vaccine Help Save Kids With Brain Cancer?

By: Laura Goldman, Care2.com, April 17, 2017 The statistics are grim: About 60 to 70 percent of children who have glioblastoma, a form of brain cancer, do not survive more than two years. This fast-growing cancer is resistant to traditional treatments like radiation and chemotherapy. For dogs, cancer statistics are also grim. More than 6

Biomarker Could Lead to Personalized Therapies for Prostate Cancer

Protein testing could aid clinicians in the proper diagnosis and treatment of the disease April 05, 2017 Story Contact: Jeff Sossamon COLUMBIA, Mo. – In 2016, more than 181,000 new cases of prostate cancer were reported in the U.S., according to the American Cancer Society. The prostate-specific antigen (PSA) test is one of the earliest ways

$3.6 million to fund personalized 3-D brain maps to guide neurosurgeries

Academic-industry partnership aims to improve brain surgery By Tamara Bhandari April 5, 2017 Neurosurgeons must avoid cutting into parts of the brain responsible for key functions such as language (orange) and vision (green), but individuals vary in where such functions are located (each of the top images compared with the bottom images above). Researchers are creating

Rogue breast tumor proteins point to potential drug therapies

Such treatment options are missed by genomic sequencing By Julia Ezangelou Strait March 28, 2017 For patients with difficult-to-treat cancers, doctors increasingly rely on genomic testing of tumors to identify errors in the DNA that indicate a tumor can be targeted by existing therapies. But this approach overlooks another potential marker — rogue proteins — that may

Mystery of Memory Cells Answered Through Mouse Study

March 13, 2017 New findings could impact vaccination, cancer research When an infection attacks the body for the first time, T cells of the immune system help fight off that specific pathogen. After the infection has cleared, some of the T cells that fought the microbe transition into "memory" cells that remember the pathogen and

UCSF researchers find key to ‘tired’ blood and immune systems

Aging of Blood-Forming Stem Cells Is Linked to Defect in Cellular Recycling Process By Jeff Norris on March 02, 2017 A molecular key to aging of the blood and immune system has been discovered in new research conducted at UC San Francisco, raising hope that it may be possible to find a way to slow

Novel ‘Barcode’ tracking T-cells in Immunotherapy Patients identifies likely cancer

Wed, 03/01/2017 - 10:17am by Fred Hutchinson Cancer Research Center A new discovery by researchers at the Fred Hutchinson Cancer Research Center in Seattle makes an important step in identifying which specific T cells within the diverse army of a person's immune system are best suited to fight cancer. The findings will be published February

Laser technique measures the stiffnes of cancer cells

Tue, 02/28/2017 - 3:03pm by Duke University Biomedical engineers at Duke University have discovered a way to detect signs of cancer on a cell-by-cell basis using two lasers and a camera. Several medical devices currently in use and in clinical trials around the world look for increases in cellular stiffness as an indicator of cancerous